Interleukin Genetics, Inc. Director Compensation Policy (Effective April 29, 2010)

Summary

This policy outlines the compensation for non-employee, non-Series A directors of Interleukin Genetics, Inc. Directors receive an annual retainer of $20,000, additional retainers for committee roles, and $1,500 for each meeting attended. New directors are granted an option to purchase 15,000 shares of company stock, vesting over four years. The policy specifies the structure and terms of director compensation for their service to the company.

EX-10.1 2 v193469_ex10-1.htm

Exhibit 10.1

INTERLEUKIN GENETICS, INC.

DIRECTOR COMPENSATION POLICY

(effective April 29, 2010)

Each non-employee director of Interleukin Genetics, Inc. (the “Company”) who is also not a Series A director is entitled to receive compensation for his service as a director in accordance with the following policy:

for service as a director, an annual retainer of $20,000;

for service as the chair of a committee, an annual retainer of $7,500;

for service as a non-chair member of a committee, an annual retainer of $5,000;

for each Board or committee meeting attended in person, by teleconference or by video, $1,500; and

upon initial election or appointment to the Board, a grant of an option to purchase 15,000 shares of the Company’s common stock at an exercise price equal to the closing price of the common stock on the date of grant, with such option to vest in four equal annual installments on each of the first four anniversaries of the grant date.